4.5 Article

Interleukin-25 enhances humoral immune responses caused by the rabies virus

Related references

Note: Only part of the references are listed.
Article Microbiology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model

Drishya Kurup et al.

Summary: The study developed an inactivated rabies virus vectored vaccine platform, resulting in a vaccine against SARS-CoV-2 named CORAVAX. CORAVAX demonstrated effectiveness in preventing viral replication and lung disease in hamster models, showing potential for robust immune responses in humans.

PLOS PATHOGENS (2021)

Article Dentistry, Oral Surgery & Medicine

IL-25 promotes Th2-type reactions and correlates with disease severity in the pathogenesis of oral lichen planus

Hui Wang et al.

ARCHIVES OF ORAL BIOLOGY (2019)

Article Genetics & Heredity

Using rabies virus vaccine strain SRV9 as viral vector to express exogenous gene

Hualei Wang et al.

VIRUS GENES (2015)

Review Immunology

Functional Specialization of Interleukin-17 Family Members

Yoichiro Iwakura et al.

IMMUNITY (2011)

Article Biochemical Research Methods

An improved method for recovering rabies virus from cloned cDNA

K Inoue et al.

JOURNAL OF VIROLOGICAL METHODS (2003)

Article Biochemistry & Molecular Biology

IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1

J Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Review Immunology

Type 1 type 2 immunity in infectious diseases

B Spellberg et al.

CLINICAL INFECTIOUS DISEASES (2001)